Supporting Improved Patient Onboarding and Adherence With Training Solutions

With more biologics and drug delivery device options entering the market in recent years, pharma companies can decide whether it would be easier for patients to self-inject with an autoinjector or prefilled syringe, depending on drug viscosity and other factors. Some biologics also offer patients and their healthcare providers (HCPs) the ability to choose [...]

Response to News Release from 215 Biopharma KOLs

In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn of a golden age of medicine [which] will soon have the ability to treat and cure diseases that have long been untreatable and incurable.” [...]

How Well Are Your Rheumatology Patients Self-Administering Their Medication?

A primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options, it has become crucial for these HCPs to understand just how well their rheumatology patients are self-administering their medications. Currently, most RA patients undergo a [...]

DermWireTV: Noble Educates on Self-Injection

Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates trainers for autoinjectors intended to increase patient confidence and autonomy with self-managed treatments. Watch full clip>

Training Diabetes Patients on Self-Injection Is Essential

Ensuring that diabetes patients correctly administer their insulin or glucagon is a priority for prescribers and patients alike. Keeping tabs on the extent to which patients are (or are not) taking their medications as prescribed, however, is increasingly complicated due to technical innovations in drug delivery. Read full article >

Gaps in Training, Poor Adherence Highlight Need For Dermatologists To Demand Improved Onboarding Tools

Desperate for relief, many people living with psoriasis and atopic dermatitis rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% of patients who skip or altogether avoid injections due to anxiety or fear—proper training and onboarding is critical. Even more alarming is that nearly [...]

Gaps in Training, Poor Adherence Highlight Need For Rheumatologists To Demand Improved Onboarding Tools

Desperate for relief, many people living with rheumatoid arthritis (RA) and other chronic conditions rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% of patients who skip or altogether avoid injections due to anxiety or fear—proper training and onboarding is critical. Even more alarming [...]

Injection Devices: As Self-Injection Grows, Drug Delivery Gets Smarter

The global injectable drug delivery market is growing around 11.8% CAGR and will soon eclipse oral delivery as the most valuable route of administration of pharmaceuticals. The market was valued at $328 million in 2015 and is expected to reach $640 million by 2021. This growth is being fueled by biologics, which are expected [...]

Can Realistic Training Devices Help Make a Blockbuster?

Innovation is vital for survival in the pharma industry. Although huge amounts of time, money and creativity are conventionally spent on the clinical development and commercialization of new drugs, success in the modern marketplace sometimes requires a wider perspective. For example, even the most effective drug won’t find success if patients simply aren’t comfortable [...]